Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, presented data today from a study showing that its ...

A precision oncology company specializing in blood- and tissue-based genomic profiling to inform cancer treatment decisions.

Diagnostics company Guardant Health (NASDAQ:GH) will be reporting earnings tomorrow after market hours. Here’s what you need ...

This May, take action, raise your voice, and help change the conversation around mental health! Since 1949, Mental Health Awareness Month has been a driving force in addressing the challenges faced by ...

Precision oncology company Guardant Health has announced a strategic collaboration with Pfizer to support the development and ...

Guardant Health (GH) announced a strategic collaboration with Pfizer (PFE) to support the development and commercialization of Pfizer’s ...

Guardant Health (GH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Guardant Health Inc. stock grades by Barron's. View GH fundamental and sentiment analysis powered by MarketGrader.

The Public Health Agency of Canada is part of the federal health portfolio. Our activities focus on protecting against threats to public health, preventing and reducing diseases and injury, and ...

What a time it’s been for Guardant Health. In the past six months alone, the company’s stock price has increased by a massive ...

The American Cancer Society recommends people at average risk of colorectal cancer start screening at age 45, now several ...